chronic insomnia

Pear Therapeutics launches Somryst for the treatment of chronic insomnia
By Mallory Hackett | 12:18 pm | November 17, 2020
 The cognitive behavioral therapy for insomnia program is designed to be an end-to-end virtual experience. 
Pear's Somryst precursor improved sleep health measures among patients with chronic insomnia and depressive symptoms
By Dave Muoio | 02:40 pm | August 31, 2020
The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.
FDA clears Pear's digital insomnia therapeutic through 510(k), Pre-Cert pilot pathways
By Dave Muoio | 04:53 pm | March 26, 2020
Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces.